BCL2 and gastric cancer: Moreover, Hesperidin (100 μM) could change cell morphology i,e, chromatin condensation, and apoptosis markers like alter Bcl-2, caspase-3 activation in SNU-668 human gastric cells possible usage of hesperidin in gastric cancer patients [99].